SCHEMBL6196346

SCHEMBL6196346

c1ncc2c[nH]ncc1-2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31590130 0.90 AKT2 (0.54)
SCHEMBL30557158 0.90 AKT2 (0.54)
SCHEMBL3740850 0.88 AKT2 (0.70)
Hydrochloric Acid SCHEMBL28973063 0.85 AKT2 (0.67)
SCHEMBL23292140 0.80 FDPS (0.47)
SCHEMBL29464728 0.80 FDPS (0.47)
SCHEMBL320681 0.80 CYP2A6 (0.46)
SCHEMBL16432987 0.80 AKT2 (0.76)
SCHEMBL29533228 0.80 AKT2 (0.61)
SCHEMBL15689115 0.80 AKT2 (0.76)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026103730-A1 DIAZAHETEROCYCLIC DERIVATIVE OF PYRIDOARYL GROUP HAVING KAPPA RECEPTOR ANTAGONISTIC ACTIVITY AND COMPOSITION THEREOF, AND USE 江苏恩华药业股份有限公司 2026-05-21 WO disclosed
EP-1539168-A2 TREATMENT OF NEUROPATHIC PAIN WITH 6H-PYRROLO(3,4-D)PYRIDAZINE COMPOUNDS Merck & Co., Inc. (US) 2005-06-15 EP disclosed
WO-2004006836-A2 TREATMENT OF NEUROPATHIC PAIN WITH 6H-PYRROLO[3,4-D]PYRIDAZINE COMPOUNDS MERCK & CO., INC. (US) 2004-01-22 WO disclosed